Items where authors include "Griffiths, R."

Article

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G. orcid.org/0000-0002-9952-8440, Brown, S. orcid.org/0000-0002-7975-7537 et al. (24 more authors) (2023) Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM). Journal of Clinical Oncology. JCO2300236. ISSN 0732-183X

Hilton, C., Morris, A., Burnside, G. et al. (22 more authors) (2023) A two-arm, randomised feasibility trial using link workers to improve dental visiting in people with severe mental illness: A protocol paper. Pilot and Feasibility Studies, 9. 157. ISSN 2055-5784

Brown, J.E. orcid.org/0000-0003-4960-3032, Royle, K.-L., Gregory, W. et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Carey, T.A., Huddy, V. orcid.org/0000-0002-0567-8166 and Griffiths, R. (2019) To mix or not to mix? A meta-method approach to rethinking evaluation practices for improved effectiveness and efficiency of psychological therapies illustrated with the application of perceptual control theory. Frontiers in Psychology, 10. 1445. ISSN 1664-1078

Hardy-Werbin, M., Rocha, P., Arpi, O. et al. (13 more authors) (2019) Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. OncoImmunology, 8 (6). e1593810. ISSN 2162-4011

Hardy-Werbin, M., Arpi, O., Taus, A. et al. (10 more authors) (2018) Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. OncoImmunology, 7 (2). e1395125. ISSN 2162-402X

Carey, T.A., Tai, S.J., Mansell, W. et al. (3 more authors) (2017) Improving professional psychological practice through an increased repertoire of research methodologies : illustrated by the development of MOL. Professional Psychology: Research and Practice, 48 (3). pp. 175-182. ISSN 0735-7028

Arriola, E., Wheater, M., Galea, I. et al. (13 more authors) (2016) Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11 (9). pp. 1511-1521. ISSN 1556-0864

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.

George, T., Wen, Q., Griffiths, R. et al. (3 more authors) (2009) Human Pif1 helicase unwinds synthetic DNA structures resembling stalled DNA replication forks. Nucleic Acids Research, 37 (19). pp. 6491-6502. ISSN 0305-1048

Monograph

Banerjee, J., Baxter, M., Coats, T. et al. (8 more authors) (2017) Major Trauma in Older People. Report. The Trauma Audlt & Research Network , Manchester.